합성 생물학 시장 – 2029년까지 세계 예측

Synthetic Biology Market – Global Forecast to 2029

합성 생물학 시장 – 도구 (올리고 뉴클레오타이드, 효소, 합성 세포), 기술 (시퀀싱, 생물 정보학), 용도 (창약, 조직 재생, 바이오 연료, 식품, 농업, 소비자 관리, 환경) – 2029년까지 세계 예측

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) – Global Forecast to 2029

　　　　주문/문의　　　　조사회사/라이센스/납기안내

Report Overview

The global synthetic biology market is projected to surpass USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%.

세계의 합성 생물학 시장은 2024년 123억 3,000만 달러에서 2029년에는 315억 2,000만 달러를 넘어 20.6%라는 대폭적인 CAGR로 성장할 것으로 예측되고 있습니다.

The excessive demand for bio-based products is providing momentum to the market growth. Furthermore, rising investment by key market players and increasing funding in R&D & collaborations in the synthetic biology market to meet the needs of both local and international markets is further driving the market growth. The development of CRISPR and other gene-editing technologies opened new avenues for the synthetic biology sector. These advanced technologies enable precise gene modifications, accelerating advancements in therapeutic applications and agriculture fueling the growth of the synthetic biology market.

“The oligonucleotide & synthetic DNA synthetic biology segment accounted for the highest share in 2023.”

On the basis of tools, the synthetic biology market is further segmented into xeno nucleic acids, enzymes, chassis organisms, cloning technology kits, oligonucleotides and synthetic DNA, and synthetic cells. The oligonucleotides and synthetic DNA dominated the market and anticipated to grow at a significant CAGR during the forecast period. Rise in the use of oligonucleotides and synthetic DNA in environmental, food, and industrial sectors, expansion of synthetic biology companies in in areas such as agriculture, energy, and industrial biotechnology are some of the major factors driving the segmental growth.

“By applications, medical applications segment accounted for the largest share in the synthetic biology market.”

The applications segment in the synthetic biology market is segmented into medical applications, industrial applications, food, animal health & agricultural applications and environmental applications. The medical applications segment dominated the market share owing to  the increasing prevalence of chronic diseases and genetic disorders which is driving demand for innovative medical solutions. Furthermore, with advancements in gene editing and synthetic microbes, researchers can develop targeted therapies, personalized medicine, and even engineered vaccines.

“North America: the largest share of the synthetic biology market”

By region, the market is segment into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America dominated the synthetic biology market in 2023 and is estimated to continue dominance during the forecast period. Presence of dominant market players in pharmaceutical and biotechnological companies in the region, strong base of synthetic biology manufacturers such as Thermo Fisher Scientific Inc. and Agilent Technologies Inc. are some of the prominent factors acerating market growth.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the synthetic biology market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Novozymes A/S (Denmark), Agilent Technologies Inc. (US), Eurofins Scientific (Luxembourg), Amyris, Inc. (US), Twist Bioscience (US), Codexis, Inc. (US), Genscript (US), Ginkgo Bioworks (US), Precigen (US), Creative Enzymes (US), Synthego (US), Viridos (US), and Cyrus Biotechnology (US)  are some of the major players operating in the synthetic biology market.

Research Coverage:

This research report categorizes the synthetic biologys market tools (oligonucleotides & synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno nucleic acids and synthetic cells), technologies (measurement and modeling, genome engineering, gene synthesis, cloning, site-directed mutagenesis, microfluidics, sequencing, nanotechnology and bioinformatics), and applications (medical applications, industrial applications, food, animal health & agricultural applications and environmental applications) and region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the synthetic biologys market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the synthetic biology market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the synthetic biology and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (diverse applications of synthetic biology, increasing demand for bio-based products, advancements in synthetic biology, rising funding in R&D and collaborations), restraints (production scalability, ethical and regulatory challenges), opportunities (rising opportunities for agricultural synthetic biology, growing use of artificial intelligence and machine learning) and Challenges (Cost constraints) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on upcoming technologies in synthetic biology manufacturing, research and development activities, and new product launches in the synthetic biology market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the synthetic biology market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Novozymes A/S (Denmark), Eurofins Scientific (Luxembourg), Agilent Technologies Inc. (US), among others in the market.

Table of Contents

1               INTRODUCTION              45

1.1           STUDY OBJECTIVES       45

1.2           MARKET DEFINITION   45

1.3           STUDY SCOPE   46

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      46

1.3.2        INCLUSIONS AND EXCLUSIONS 47

1.3.3        YEARS CONSIDERED      47

1.3.4        CURRENCY CONSIDERED            47

1.4           STAKEHOLDERS               48

1.5           SUMMARY OF CHANGES               48

2               RESEARCH METHODOLOGY       49

2.1           RESEARCH DATA              49

2.1.1        SECONDARY DATA          50

2.1.2        PRIMARY DATA 51

2.2           MARKET ESTIMATION METHODOLOGY               52

2.2.1        MARKET SIZE ESTIMATION         52

2.2.2        INSIGHTS FROM PRIMARY EXPERTS        54

2.2.3        TOP-DOWN APPROACH                55

2.3           MARKET GROWTH RATE PROJECTION  56

2.4           DATA TRIANGULATION                58

2.5           RESEARCH ASSUMPTIONS           59

2.6           RESEARCH LIMITATIONS             60

2.7           RISK ANALYSIS  60

3               EXECUTIVE SUMMARY  61

4               PREMIUM INSIGHTS       65

4.1           SYNTHETIC BIOLOGY MARKET OVERVIEW         65

4.2           NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION

AND COUNTRY (2023)    66

4.3           SYNTHETIC BIOLOGY MARKET SHARE, BY APPLICATION, 2024 VS. 2029        67

4.4           SYNTHETIC BIOLOGY MARKET, BY REGION        67

5               MARKET OVERVIEW       68

5.1           INTRODUCTION              68

5.2           MARKET DYNAMICS       68

5.2.1        DRIVERS               69

5.2.1.1    Diverse applications of synthetic biology          69

5.2.1.2    Surging demand for bio-based products           70

5.2.1.3    Advancements in synthetic biology   70

5.2.1.4    Increasing funding in R&D and collaborations                71

5.2.2        RESTRAINTS      73

5.2.2.1    Production scalability          73

5.2.2.2    Ethical and regulatory challenges      74

5.2.3        OPPORTUNITIES              75

5.2.3.1    Rising opportunities for agricultural synthetic biology  75

5.2.3.2    Growing integration of artificial intelligence and machine learning  76

5.2.4        CHALLENGES    76

5.2.4.1    Cost constraints    76

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            77

5.4           VALUE CHAIN ANALYSIS               78

5.5           ECOSYSTEM ANALYSIS  80

5.5.1        PRODUCT/SERVICE PROVIDERS               80

5.5.2        END USERS         82

5.5.3        REGULATORY LANDSCAPE         82

5.6           TECHNOLOGY ANALYSIS             83

5.6.1        KEY TECHNOLOGIES     83

5.6.1.1    DNA synthesis and sequencing          83

5.6.1.2    Gene editing tools                 84

5.6.1.3    Bioinformatics and computational tools           84

5.6.1.4    Nanotechnology    85

5.6.2        COMPLEMENTARY TECHNOLOGIES       86

5.6.2.1    Cellular and tissue engineering          86

5.6.3        ADJACENT TECHNOLOGIES       87

5.6.3.1    Metabolic engineering         87

5.7           PATENT ANALYSIS          87

5.7.1        METHODOLOGY              87

5.7.2        NUMBER OF PATENTS FILED     87

5.7.3        INNOVATION AND PATENT APPLICATIONS        88

5.8           PRICING ANALYSIS          90

5.8.1        INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER 90

5.8.2        INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION                 91

5.9           KEY CONFERENCES & EVENTS, 2024–2025              92

5.10         REGULATORY LANDSCAPE         93

5.10.1      REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

5.10.2      REGULATORY FRAMEWORK       96

5.11         INVESTMENT & FUNDING SCENARIO     97

5.12         PORTER’S FIVE FORCES ANALYSIS           98

5.12.1      INTENSITY OF COMPETITIVE RIVALRY 99

5.12.2      BARGAINING POWER OF SUPPLIERS       99

5.12.3      BARGAINING POWER OF BUYERS             99

5.12.4      THREAT OF SUBSTITUTES          99

5.12.5      THREAT OF NEW ENTRANTS      99

5.13         KEY STAKEHOLDERS & BUYING CRITERIA            100

5.13.1      KEY BUYING CRITERIA  101

5.14         IMPACT OF AI ON SYNTHETIC BIOLOGY MARKET                 102

6               SYNTHETIC BIOLOGY MARKET, BY TOOL            104

6.1           INTRODUCTION              105

6.2           OLIGONUCLEOTIDES & SYNTHETIC DNA             105

6.2.1        SURGING DEMAND FOR SYNTHETIC GENES TO SUPPORT MARKET GROWTH     105

6.3           ENZYMES             109

6.3.1        WIDE POTENTIAL OF ENZYME ENGINEERING IN OMICS STUDIES

TO PROPEL MARKET      109

6.4           CLONING TECHNOLOGY KITS  113

6.4.1        ALTERATION AND OPTIMIZATION OF GENETIC CIRCUIT DESIGNS

BY MOLECULAR BIOLOGY TECHNIQUES TO DRIVE MARKET                 113

6.5           SYNTHETIC CELLS           116

6.5.1        GROWING POPULARITY OF SYNTHETIC CELLS AS SUBSTITUTES FOR NATURAL CELLS TO BOOST MARKET GROWTH             116

6.6           CHASSIS ORGANISMS     121

6.6.1        INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET               121

6.7           XENO NUCLEIC ACIDS  124

6.7.1        SPIKE IN DEMAND FOR BREAKTHROUGH MEDICINES TO

AID MARKET GROWTH 124

7               SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY                 128

7.1           INTRODUCTION              129

7.2           GENE SYNTHESIS             129

7.2.1        RISING DEMAND FOR SYNTHETIC GENES AND INCREASING COMPETITIVENESS AMONG MARKET PLAYERS TO SPUR MARKET GROWTH               129

7.3           GENOME ENGINEERING               134

7.3.1        SURGING NEED FOR RAPID, CHEAP, AND MULTIPLEX MODIFICATION OF GENOMES TO DRIVE MARKET           134

7.4           SEQUENCING    138

7.4.1        RISING ADOPTION OF SEQUENCING TECHNOLOGY TO

BOOST MARKET GROWTH           138

7.5           BIOINFORMATICS           142

7.5.1        INCREASING ADVANCEMENTS AND RISING USE OF BIOINFORMATICS TO PROPEL MARKET GROWTH           142

7.6           CLONING             145

7.6.1        PRECISE GENETIC REPLICATION TO ACCELERATE RESEARCH AND

SCALING APPLICATIONS ACROSS VARIOUS INDUSTRIES                 145

7.7           SITE-DIRECTED MUTAGENESIS 149

7.7.1        WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET                 149

7.8           MEASUREMENT & MODELING   152

7.8.1        INCREASING DEMAND FOR CELL-FREE SYNTHETIC BIOLOGY TO

FOSTER MARKET GROWTH         152

7.9           MICROFLUIDICS               156

7.9.1        RISING FOCUS ON INCREASING SCALABILITY OF SYNTHETIC BIOLOGY TOOLS TO PROPEL MARKET GROWTH                 156

7.10         NANOTECHNOLOGY     159

7.10.1      CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY TO AID MARKET GROWTH               159

8               SYNTHETIC BIOLOGY MARKET, BY APPLICATION                 163

8.1           INTRODUCTION              164

8.2           MEDICAL APPLICATIONS             164

8.2.1        PHARMACEUTICALS       168

8.2.1.1    Potential of synthetic biology techniques in development of active pharmaceutical ingredients to drive market          168

8.2.2        DRUG DISCOVERY & THERAPEUTICS     172

8.2.2.1    Cancer detection & diagnostics          176

8.2.2.1.1 Increasing investments in cancer research to

support market growth        176

8.2.2.2    Other drug discovery & therapeutic applications            179

8.2.3        ARTIFICIAL TISSUE & TISSUE REGENERATION   183

8.2.3.1    Biosynthesis          187

8.2.3.1.1 Expansive design space enabled by synthetic biology to foster market growth       187

8.2.3.2    Stem cell regulation              190

8.2.3.2.1 Stem cell research to accelerate market growth               190

8.2.3.3    Other artificial tissue & tissue regeneration applications                 194

8.3           INDUSTRIAL APPLICATIONS      197

8.3.1        BIOFUELS & RENEWABLE ENERGY           202

8.3.1.1    Advantages of using genetically engineered organisms for synthetic production of biofuels to propel market growth              202

8.3.2        INDUSTRIAL ENZYMES 205

8.3.2.1    Textile industry    209

8.3.2.1.1 Surge in demand for increasing reaction rates and reducing costs to foster market growth       209

8.3.2.2    Paper industry      213

8.3.2.2.1 Increasing use of enzymes in pulp and paper industry to favor market growth       213

8.3.2.3    Consumer care industry      216

8.3.2.3.1 Skincare & cosmetics           221

8.3.2.3.1.1              Benefits offered by synthetic biology technologies in manufacturing of skincare and cosmetic products to propel market growth                 221

8.3.2.3.2 Other consumer care products           224

8.3.2.4    Other industries   228

8.3.3        BIOMATERIALS & GREEN CHEMICALS    231

8.3.3.1    Production of green chemicals through microbial fermentation to drive market          231

8.4           FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS 234

8.4.1        FLAVORS & FRAGRANCES             239

8.4.1.1    Rising demand for natural, sustainable products to

bolster market growth          239

8.4.2        OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS 242

8.5           ENVIRONMENTAL APPLICATIONS           246

8.5.1        BIOREMEDIATION          250

8.5.1.1    Increasing need for cost-effective, on-site environmental monitoring methods to boost market                 250

8.5.2        BIOSENSING      253

8.5.2.1    Growing interest in development of whole-cell biosensors

to drive market      253

9               SYNTHETIC BIOLOGY MARKET, BY REGION        257

9.1           INTRODUCTION              258

9.2           NORTH AMERICA             258

9.2.1        NORTH AMERICA: MACROECONOMIC OUTLOOK                 266

9.2.2        US           267

9.2.2.1    Rising investment in synthetic biology companies and surging demand for bio-based products to drive market              267

9.2.3        CANADA               273

9.2.3.1    Strong research infrastructure and availability of funding to

support market growth        273

9.3           EUROPE               278

9.3.1        EUROPE: MACROECONOMIC OUTLOOK               284

9.3.2        GERMANY           285

9.3.2.1    Government initiatives and increasing funding to propel

market growth       285

9.3.3        UK          291

9.3.3.1    Increasing R&D expenditure to favor market growth     291

9.3.4        FRANCE                297

9.3.4.1    Investments aimed at increasing research in various biomedical fields to augment market growth       297

9.3.5        SWITZERLAND 302

9.3.5.1    Established biotech ecosystem, strong academic institutions, and favorable government policies to favor market growth   302

9.3.6        DENMARK           307

9.3.6.1    Presence of third-largest commercial drug development pipeline in Europe to favor market growth      307

9.3.7        ITALY    312

9.3.7.1    Increasing life sciences R&D funded by both public and private organizations to foster market            312

9.3.8        SPAIN    317

9.3.8.1    Well-established network of research centers, universities, and hospitals to support market growth   317

9.3.9        REST OF EUROPE             322

9.4           ASIA PACIFIC     328

9.4.1        ASIA PACIFIC: MACROECONOMIC OUTLOOK     335

9.4.2        CHINA  336

9.4.2.1    Rising growth opportunities for pharmaceutical and biopharmaceutical companies to drive market 336

9.4.3        JAPAN   342

9.4.3.1    Growing awareness of synthetic biology’s importance and potential applications to accelerate market growth         342

9.4.4        INDIA    347

9.4.4.1    Increasing R&D activities and government funding initiatives to bolster market growth          347

9.4.5        AUSTRALIA         353

9.4.5.1    Increasing funding for synthetic biology research to

accelerate market growth    353

9.4.6        SOUTH KOREA  358

9.4.6.1    Increasing focus on developing biotechnology and pharmaceutical sectors to boost market            358

9.4.7        REST OF ASIA PACIFIC   363

9.5           LATIN AMERICA                369

9.5.1        LATIN AMERICA: MACROECONOMIC OUTLOOK                 375

9.5.2        BRAZIL 376

9.5.2.1    Growing life sciences and pharmaceutical industry to fuel demand for synthetic biological products         376

9.5.3        MEXICO                381

9.5.3.1    Increasing support for biotechnology infrastructure development to augment market growth  381

9.5.4        REST OF LATIN AMERICA             386

9.6           MIDDLE EAST   391

9.6.1        MIDDLE EAST: MACROECONOMIC OUTLOOK   397

9.6.2        GCC COUNTRIES              398

9.6.2.1    KSA        403

9.6.2.2    UAE        409

9.6.2.3    Rest of GCC countries         414

9.6.3        REST OF MIDDLE EAST 419

9.7           AFRICA 424

9.7.1        AFRICA: MACROECONOMIC OUTLOOK 429

10            COMPETITIVE LANDSCAPE         431

10.1         OVERVIEW          431

10.2         KEY PLAYER STRATEGY/RIGHT TO WIN                431

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN

SYNTHETIC BIOLOGY MARKET 432

10.3         REVENUE ANALYSIS       433

10.4         MARKET SHARE ANALYSIS           434

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 436

10.5.1      STARS   436

10.5.2      EMERGING LEADERS     436

10.5.3      PERVASIVE PLAYERS      436

10.5.4      PARTICIPANTS 437

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         438

10.5.5.1  Company footprint               438

10.5.5.2  Region footprint   439

10.5.5.3  Tool footprint        439

10.5.5.4  Technology footprint           440

10.5.5.5  Application footprint            441

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        442

10.6.1      PROGRESSIVE COMPANIES         442

10.6.2      RESPONSIVE COMPANIES            442

10.6.3      DYNAMIC COMPANIES  442

10.6.4      STARTING BLOCKS         442

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 444

10.7         COMPANY VALUATION & FINANCIAL METRICS, 2023                 446

10.7.1      FINANCIAL METRICS      446

10.7.2      COMPANY VALUATION 446

10.8         BRAND/PRODUCT COMPARISON             447

10.9         COMPETITIVE SCENARIO             448

10.9.1      PRODUCT LAUNCHES   448

10.9.2      DEALS  449

10.9.3      EXPANSIONS     450

11            COMPANY PROFILES      452

11.1         KEY PLAYERS     452

11.1.1      THERMO FISHER SCIENTIFIC INC.            452

11.1.1.1  Business overview 452

11.1.1.2  Products/Services offered   453

11.1.1.3  Recent developments           455

11.1.1.3.1                Product launches  455

11.1.1.3.2                Deals      455

11.1.1.3.3                Expansions             456

11.1.1.4  MnM view              456

11.1.1.4.1                Key strengths        456

11.1.1.4.2                Strategic choices   456

11.1.1.4.3                Weaknesses & competitive threats     457

11.1.2      MERCK KGAA    458

11.1.2.1  Business overview 458

11.1.2.2  Products/Services offered   459

11.1.2.3  Recent developments           461

11.1.2.3.1                Deals      461

11.1.2.4  MnM view              461

11.1.2.4.1                Key strengths        461

11.1.2.4.2                Strategic choices   462

11.1.2.4.3                Weaknesses & competitive threats     462

11.1.3      NOVOZYMES A/S              463

11.1.3.1  Business overview 463

11.1.3.2  Products/Services offered   464

11.1.3.3  Recent developments           465

11.1.3.3.1                Product launches  465

11.1.3.3.2                Deals      466

11.1.3.4  MnM view              467

11.1.3.4.1                Key strengths        467

11.1.3.4.2                Strategic choices   467

11.1.3.4.3                Weaknesses & competitive threats     467

11.1.4      EUROFINS SCIENTIFIC  468

11.1.4.1  Business overview 468

11.1.4.2  Products/Services offered   469

11.1.5      AGILENT TECHNOLOGIES INC. 471

11.1.5.1  Business overview 471

11.1.5.2  Products/Services offered   472

11.1.5.3  Recent developments           474

11.1.5.3.1                Products launches                 474

11.1.5.3.2                Deals      474

11.1.5.3.3                Expansions             475

11.1.6      AMYRIS, INC.      476

11.1.6.1  Business overview 476

11.1.6.2  Products/Services offered   476

11.1.6.3  Recent developments           477

11.1.6.3.1                Deals      477

11.1.7      CODEXIS, INC.   478

11.1.7.1  Business overview 478

11.1.7.2  Products/Services offered   479

11.1.7.3  Recent developments           481

11.1.7.3.1                Product launches  481

11.1.7.3.2                Deals      481

11.1.7.3.3                Expansions             482

11.1.8      TWIST BIOSCIENCE        483

11.1.8.1  Business overview 483

11.1.8.2  Products/Services offered   484

11.1.8.3  Recent developments           485

11.1.8.3.1                Product launches  485

11.1.8.3.2                Deals      487

11.1.8.3.3                Expansions             488

11.1.9      GENSCRIPT        489

11.1.9.1  Business overview 489

11.1.9.2  Products/Services offered   490

11.1.9.3  Recent developments           492

11.1.9.3.1                Product launches  492

11.1.9.3.2                Deals      493

11.1.9.3.3                Other developments             493

11.1.10   PRECIGEN           494

11.1.10.1                 Business overview 494

11.1.10.2                 Products/Services offered   495

11.1.11   GINKGO BIOWORKS       497

11.1.11.1                 Business overview 497

11.1.11.2                 Products/Services offered   498

11.1.11.3                 Recent developments           499

11.1.11.3.1             Product launches  499

11.1.11.3.2             Deals      499

11.1.12   VIRIDOS               503

11.1.12.1                 Business overview 503

11.1.12.2                 Products/Services offered   504

11.1.12.3                 Recent developments           505

11.1.12.3.1             Product launches  505

11.1.12.3.2             Deals      507

11.1.12.3.3             Other developments             508

11.1.13   SYNTHEGO         509

11.1.13.1                 Business overview 509

11.1.13.2                 Products/Services offered   509

11.1.13.3                 Recent developments           511

11.1.13.3.1             Product launches  511

11.1.13.3.2             Deals      512

11.1.13.3.3             Expansions             512

11.1.14   CREATIVE ENZYMES      513

11.1.14.1                 Business overview 513

11.1.14.2                 Products/Services offered   513

11.1.15   CYRUS BIOTECHNOLOGY            515

11.1.15.1                 Business overview 515

11.1.15.2                 Products/Services offered   515

11.1.15.3                 Recent developments           516

11.1.15.3.1             Deals      516

11.2         OTHER PLAYERS              517

11.2.1      ATUM   517

11.2.2      TESELAGEN       518

11.2.3      ARZEDA                519

11.2.4      INTEGRATED DNA TECHNOLOGIES, INC.             520

11.2.5      NEW ENGLAND BIOLABS              522

11.2.6      ELEVATEBIO     523

11.2.7      ZENFOLD (IOSYNTH)    524

11.2.8      SYNBIO TECHNOLOGIES              525

11.2.9      INSCRIPTA, INC.               526

11.2.10   CRISPR THERAPEUTICS                 526

12            APPENDIX           527

12.1         DISCUSSION GUIDE        527

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                533

12.3         CUSTOMIZATION OPTIONS        535

12.4         RELATED REPORTS         535

12.5         AUTHOR DETAILS           536

LIST OF TABLES

TABLE 1                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              57

TABLE 2                SYNTHETIC BIOLOGY MARKET: RISK ASSESSMENT ANALYSIS 60

TABLE 3                ROLE OF COMPANIES IN ECOSYSTEM    81

TABLE 4                KEY END USERS IN SYNTHETIC BIOLOGY MARKET               82

TABLE 5                KEY REGULATORY BODIES IN SYNTHETIC BIOLOGY MARKET          82

TABLE 6                NUMBER OF PATENTS FILED IN SYNTHETIC BIOLOGY MARKET,

BY DOCUMENT TYPE, 2014–2024                87

TABLE 7                DETAILED ANALYSIS OF KEY PATENTS IN SYNTHETIC BIOLOGY MARKET, 2024      89

TABLE 8                INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER, 2023             91

TABLE 9                INDICATIVE PRICING ANALYSIS OF SYNTHETIC BIOLOGY TOOLS, BY REGION, 2023          92

TABLE 10              KEY CONFERENCES & EVENTS, JUNE 2024–DECEMBER 2025                92

TABLE 11              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

TABLE 12              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  94

TABLE 13              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  95

TABLE 14              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  95

TABLE 15              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  95

TABLE 16              REGULATIONS FOR PRODUCTS DEVELOPED USING

SYNTHETIC BIOLOGY TECHNIQUES       96

TABLE 17              SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS           98

TABLE 18              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS              100

TABLE 19              KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 101

TABLE 20              SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)       105

TABLE 21              SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA,

BY REGION, 2022–2029 (USD MILLION)   106

TABLE 22              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)     106

TABLE 23              EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)       107

TABLE 24              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)            107

TABLE 25              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)     108

TABLE 26              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)            108

TABLE 27              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)     108

TABLE 28              SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY REGION,

2022–2029 (USD MILLION)            110

TABLE 29              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)            110

TABLE 30              EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY,

2022–2029 (USD MILLION)            111

TABLE 31              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY,

2022–2029 (USD MILLION)            111

TABLE 32              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)            112

TABLE 33              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY,

2022–2029 (USD MILLION)            112

TABLE 34              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)            112

TABLE 35              SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY REGION, 2022–2029 (USD MILLION)                 113

TABLE 36              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)            114

TABLE 37              EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS,

BY COUNTRY, 2022–2029 (USD MILLION)               114

TABLE 38              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS,

BY COUNTRY, 2022–2029 (USD MILLION)               115

TABLE 39              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)            115

TABLE 40              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS,

BY COUNTRY, 2022–2029 (USD MILLION)               116

TABLE 41              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)            116

TABLE 42              SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY REGION,

2022–2029 (USD MILLION)            117

TABLE 43              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS,

BY COUNTRY, 2022–2029 (USD MILLION)               118

TABLE 44              EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)                 118

TABLE 45              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)            119

TABLE 46              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS,

BY COUNTRY, 2022–2029 (USD MILLION)               119

TABLE 47              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)            120

TABLE 48              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS,

BY COUNTRY, 2022–2029 (USD MILLION)               120

TABLE 49              SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY REGION,

2022–2029 (USD MILLION)            121

TABLE 50              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS,

BY COUNTRY, 2022–2029 (USD MILLION)               122

TABLE 51              EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)                 122

TABLE 52              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS,

BY COUNTRY, 2022–2029 (USD MILLION)               123

TABLE 53              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS,

BY COUNTRY, 2022–2029 (USD MILLION)               123

TABLE 54              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS,

BY COUNTRY, 2022–2029 (USD MILLION)               124

TABLE 55              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS,

BY COUNTRY, 2022–2029 (USD MILLION)               124

TABLE 56              SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY REGION,

2022–2029 (USD MILLION)            125

TABLE 57              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS,

BY COUNTRY, 2022–2029 (USD MILLION)               125

TABLE 58              EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)                 126

TABLE 59              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS,

BY COUNTRY, 2022–2029 (USD MILLION)               126

TABLE 60              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS,

BY COUNTRY, 2022–2029 (USD MILLION)               127

TABLE 61              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS,

BY COUNTRY, 2022–2029 (USD MILLION)               127

TABLE 62              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS,

BY COUNTRY, 2022–2029 (USD MILLION)               127

TABLE 63              SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            129

TABLE 64              SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY REGION,

2022–2029 (USD MILLION)            131

TABLE 65              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               131

TABLE 66              EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)                 132

TABLE 67              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)                 132

TABLE 68              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               133

TABLE 69              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)                 133

TABLE 70              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               133

TABLE 71              SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY REGION,

2022–2029 (USD MILLION)            135

TABLE 72              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING,

BY COUNTRY, 2022–2029 (USD MILLION)               135

TABLE 73              EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING,

BY COUNTRY, 2022–2029 (USD MILLION)               136

TABLE 74              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING,

BY COUNTRY, 2022–2029 (USD MILLION)               136

TABLE 75              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING,

BY COUNTRY, 2022–2029 (USD MILLION)               137

TABLE 76              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING,

BY COUNTRY, 2022–2029 (USD MILLION)               137

TABLE 77              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING,

BY COUNTRY, 2022–2029 (USD MILLION)               137

TABLE 78              SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY REGION,

2022–2029 (USD MILLION)            139

TABLE 79              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            139

TABLE 80              EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY,

2022–2029 (USD MILLION)            140

TABLE 81              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)                 140

TABLE 82              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            141

TABLE 83              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)                 141

TABLE 84              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)            141

TABLE 85              SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION,

2022–2029 (USD MILLION)            142

TABLE 86              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS,

BY COUNTRY, 2022–2029 (USD MILLION)               143

TABLE 87              EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)                 143

TABLE 88              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)                 144

TABLE 89              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS,

BY COUNTRY, 2022–2029 (USD MILLION)               144

TABLE 90              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)                 145

TABLE 91              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS,

BY COUNTRY, 2022–2029 (USD MILLION)               145

TABLE 92              SYNTHETIC BIOLOGY MARKET FOR CLONING, BY REGION,

2022–2029 (USD MILLION)            146

TABLE 93              NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)            146

TABLE 94              EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY,

2022–2029 (USD MILLION)            147

TABLE 95              ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY,

2022–2029 (USD MILLION)            147

TABLE 96              LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)            148

TABLE 97              MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY,

2022–2029 (USD MILLION)            148

TABLE 98              GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)            148

TABLE 99              SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY REGION, 2022–2029 (USD MILLION)            149

TABLE 100            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 101            EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               150

TABLE 102            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION) 151

TABLE 103            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)            151

TABLE 104            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION) 152

TABLE 105            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)            152

TABLE 106            SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY REGION, 2022–2029 (USD MILLION)            153

TABLE 107            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)            153

TABLE 108            EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING,

BY COUNTRY, 2022–2029 (USD MILLION)               154

TABLE 109            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING,

BY COUNTRY, 2022–2029 (USD MILLION)               154

TABLE 110            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)            155

TABLE 111            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION) 155

TABLE 112            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)            155

TABLE 113            SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY REGION,

2022–2029 (USD MILLION)            156

TABLE 114            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS,

BY COUNTRY, 2022–2029 (USD MILLION)               157

TABLE 115            EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY,

2022–2029 (USD MILLION)            157

TABLE 116            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)                 158

TABLE 117            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)            158

TABLE 118            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)                 159

TABLE 119            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS,

BY COUNTRY, 2022–2029 (USD MILLION)               159

TABLE 120            SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY REGION,

2022–2029 (USD MILLION)            160

TABLE 121            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               160

TABLE 122            EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)                 161

TABLE 123            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               161

TABLE 124            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               162

TABLE 125            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               162

TABLE 126            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               162

TABLE 127            SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              164

TABLE 128            SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            165

TABLE 129            SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            165

TABLE 130            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               166

TABLE 131            EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               166

TABLE 132            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               167

TABLE 133            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               167

TABLE 134            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               168

TABLE 135            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               168

TABLE 136            SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY REGION,

2022–2029 (USD MILLION)            169

TABLE 137            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS,

BY COUNTRY, 2022–2029 (USD MILLION)               169

TABLE 138            EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)                 170

TABLE 139            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS,

BY COUNTRY, 2022–2029 (USD MILLION)               170

TABLE 140            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 141            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 142            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 143            SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            172

TABLE 144            SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY REGION, 2022–2029 (USD MILLION)   173

TABLE 145            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)     173

TABLE 146            EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION) 174

TABLE 147            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)       174

TABLE 148            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)     175

TABLE 149            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)       175

TABLE 150            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)     175

TABLE 151            SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS,

BY REGION, 2022–2029 (USD MILLION)   176

TABLE 152            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)     177

TABLE 153            EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 177

TABLE 154            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)       178

TABLE 155            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)     178

TABLE 156            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)       179

TABLE 157            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)     179

TABLE 158            SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            180

TABLE 159            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 180

TABLE 160            EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     181

TABLE 161            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)               181

TABLE 162            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 182

TABLE 163            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)               182

TABLE 164            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 182

TABLE 165            SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            183

TABLE 166            SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2022–2029 (USD MILLION)            184

TABLE 167            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)     184

TABLE 168            EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)            185

TABLE 169            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)     185

TABLE 170            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)     186

TABLE 171            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)     186

TABLE 172            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)     186

TABLE 173            SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY REGION,

2022–2029 (USD MILLION)            187

TABLE 174            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)            188

TABLE 175            EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY,

2022–2029 (USD MILLION)            188

TABLE 176            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)                 189

TABLE 177            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)            189

TABLE 178            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)                 190

TABLE 179            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)            190

TABLE 180            SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION,

2022–2029 (USD MILLION)            191

TABLE 181            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION,

BY COUNTRY, 2022–2029 (USD MILLION)               191

TABLE 182            EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION,

BY COUNTRY, 2022–2029 (USD MILLION)               192

TABLE 183            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION,

BY COUNTRY, 2022–2029 (USD MILLION)               192

TABLE 184            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION,

BY COUNTRY, 2022–2029 (USD MILLION)               193

TABLE 185            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION,

BY COUNTRY, 2022–2029 (USD MILLION)               193

TABLE 186            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION,

BY COUNTRY, 2022–2029 (USD MILLION)               193

TABLE 187            SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)   194

TABLE 188            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            195

TABLE 189            EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 195

TABLE 190            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 196

TABLE 191            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            196

TABLE 192            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 197

TABLE 193            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            197

TABLE 194            SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            198

TABLE 195            SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            199

TABLE 196            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)       199

TABLE 197            EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               200

TABLE 198            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               200

TABLE 199            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               201

TABLE 200            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               201

TABLE 201            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)       201

TABLE 202            SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY REGION, 2022–2029 (USD MILLION)                 202

TABLE 203            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)            203

TABLE 204            EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY,

BY COUNTRY, 2022–2029 (USD MILLION)               203

TABLE 205            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION) 204

TABLE 206            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)            204

TABLE 207            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION) 205

TABLE 208            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)            205

TABLE 209            SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,

2022–2029 (USD MILLION)            206

TABLE 210            SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY REGION,

2022–2029 (USD MILLION)            206

TABLE 211            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY COUNTRY, 2022–2029 (USD MILLION)               207

TABLE 212            EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)                 207

TABLE 213            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY COUNTRY, 2022–2029 (USD MILLION)               208

TABLE 214            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY COUNTRY, 2022–2029 (USD MILLION)               208

TABLE 215            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY COUNTRY, 2022–2029 (USD MILLION)               209

TABLE 216            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY COUNTRY, 2022–2029 (USD MILLION)               209

TABLE 217            SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION,

2022–2029 (USD MILLION)            210

TABLE 218            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               210

TABLE 219            EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)                 211

TABLE 220            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)            211

TABLE 221            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               212

TABLE 222            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               212

TABLE 223            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               212

TABLE 224            SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION,

2022–2029 (USD MILLION)            213

TABLE 225            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               214

TABLE 226            EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)                 214

TABLE 227            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)                 215

TABLE 228            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               215

TABLE 229            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)                 216

TABLE 230            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               216

TABLE 231            SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,

2022–2029 (USD MILLION)            217

TABLE 232            SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2022–2029 (USD MILLION)                 217

TABLE 233            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)       218

TABLE 234            EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               218

TABLE 235            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               219

TABLE 236            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)       219

TABLE 237            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY COUNTRY, 2022–2029 (USD MILLION)               220

TABLE 238            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)       220

TABLE 239            SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY REGION,

2022–2029 (USD MILLION)            221

TABLE 240            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS,

BY COUNTRY, 2022–2029 (USD MILLION)               222

TABLE 241            EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS,

BY COUNTRY, 2022–2029 (USD MILLION)               222

TABLE 242            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS,

BY COUNTRY, 2022–2029 (USD MILLION)               223

TABLE 243            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS,

BY COUNTRY, 2022–2029 (USD MILLION)               223

TABLE 244            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS,

BY COUNTRY, 2022–2029 (USD MILLION)               224

TABLE 245            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS,

BY COUNTRY, 2022–2029 (USD MILLION)               224

TABLE 246            SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS,

BY REGION, 2022–2029 (USD MILLION)   225

TABLE 247            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)     225

TABLE 248            EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 226

TABLE 249            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)       226

TABLE 250            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)     227

TABLE 251            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)       227

TABLE 252            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)     227

TABLE 253            SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION,

2022–2029 (USD MILLION)            228

TABLE 254            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES,

BY COUNTRY, 2022–2029 (USD MILLION)               228

TABLE 255            EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)                 229

TABLE 256            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES,

BY COUNTRY, 2022–2029 (USD MILLION)               229

TABLE 257            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES,

BY COUNTRY, 2022–2029 (USD MILLION)               230

TABLE 258            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES,

BY COUNTRY, 2022–2029 (USD MILLION)               230

TABLE 259            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES,

BY COUNTRY, 2022–2029 (USD MILLION)               230

TABLE 260            SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS,

BY REGION, 2022–2029 (USD MILLION)   231

TABLE 261            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)     232

TABLE 262            EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION) 232

TABLE 263            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)       233

TABLE 264            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)     233

TABLE 265            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)       234

TABLE 266            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)     234

TABLE 267            SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                235

TABLE 268            SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          236

TABLE 269            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 236

TABLE 270            EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)               237

TABLE 271            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 237

TABLE 272            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 238

TABLE 273            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 238

TABLE 274            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 238

TABLE 275            SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY REGION,

2022–2029 (USD MILLION)            239

TABLE 276            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES,

BY COUNTRY, 2022–2029 (USD MILLION)               240

TABLE 277            EUROPE: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES,

BY COUNTRY, 2022–2029 (USD MILLION)               240

TABLE 278            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES,

BY COUNTRY, 2022–2029 (USD MILLION)               241

TABLE 279            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES,

BY COUNTRY, 2022–2029 (USD MILLION)               241

TABLE 280            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES,

BY COUNTRY, 2022–2029 (USD MILLION)               242

TABLE 281            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES,

BY COUNTRY, 2022–2029 (USD MILLION)               242

TABLE 282            SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)   243

TABLE 283            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            243

TABLE 284            EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 244

TABLE 285            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 244

TABLE 286            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            245

TABLE 287            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)                 245

TABLE 288            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)            245

TABLE 289            SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            246

TABLE 290            SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            247

TABLE 291            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            247

TABLE 292            EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               248

TABLE 293            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 248

TABLE 294            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            249

TABLE 295            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 249

TABLE 296            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            249

TABLE 297            SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION,

2022–2029 (USD MILLION)            250

TABLE 298            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION,

BY COUNTRY, 2022–2029 (USD MILLION)               251

TABLE 299            EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)                 251

TABLE 300            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)            252

TABLE 301            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION,

BY COUNTRY, 2022–2029 (USD MILLION)               252

TABLE 302            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)            253

TABLE 303            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION,

BY COUNTRY, 2022–2029 (USD MILLION)               253

TABLE 304            SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY REGION,

2022–2029 (USD MILLION)            254

TABLE 305            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)            254

TABLE 306            EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY,

2022–2029 (USD MILLION)            255

TABLE 307            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)                 255

TABLE 308            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)            256

TABLE 309            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)                 256

TABLE 310            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)            256

TABLE 311            SYNTHETIC BIOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)            258

TABLE 312            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            261

TABLE 313            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            261

TABLE 314            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            262

TABLE 315            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            262

TABLE 316            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         263

TABLE 317            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            263

TABLE 318            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)                264

TABLE 319            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 264

TABLE 320            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              265

TABLE 321            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION) 265

TABLE 322            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       265

TABLE 323            NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH,

AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            266

TABLE 324            NORTH AMERICA: KEY MACRO INDICATORS                 267

TABLE 325            US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)            268

TABLE 326            US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            269

TABLE 327            US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              269

TABLE 328            US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            270

TABLE 329            US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         270

TABLE 330            US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       271

TABLE 331            US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            271

TABLE 332            US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            272

TABLE 333            US: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            272

TABLE 334            US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            272

TABLE 335            US: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                273

TABLE 336            CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              274

TABLE 337            CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            274

TABLE 338            CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            275

TABLE 339            CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 275

TABLE 340            CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            276

TABLE 341            CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       276

TABLE 342            CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            277

TABLE 343            CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            277

TABLE 344            CANADA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         277

TABLE 345            CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         278

TABLE 346            CANADA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         278

TABLE 347            EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     279

TABLE 348            EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              280

TABLE 349            EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            280

TABLE 350            EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            281

TABLE 351            EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 281

TABLE 352            EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            282

TABLE 353            EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       282

TABLE 354            EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            283

TABLE 355            EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            283

TABLE 356            EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         283

TABLE 357            EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         284

TABLE 358            EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         284

TABLE 359            EUROPE: KEY MACRO INDICATORS         285

TABLE 360            GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              286

TABLE 361            GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            287

TABLE 362            GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            287

TABLE 363            GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 288

TABLE 364            GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            288

TABLE 365            GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       289

TABLE 366            GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         289

TABLE 367            GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              290

TABLE 368            GERMANY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         290

TABLE 369            GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL

APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        290

TABLE 370            GERMANY: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         291

TABLE 371            UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)            292

TABLE 372            UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            293

TABLE 373            UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              293

TABLE 374            UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            294

TABLE 375            UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         294

TABLE 376            UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       295

TABLE 377            UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            295

TABLE 378            UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            296

TABLE 379            UK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            296

TABLE 380            UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            296

TABLE 381            UK: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                297

TABLE 382            FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              298

TABLE 383            FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            298

TABLE 384            FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            299

TABLE 385            FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 299

TABLE 386            FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            300

TABLE 387            FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       300

TABLE 388            FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            301

TABLE 389            FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            301

TABLE 390            FRANCE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         301

TABLE 391            FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         302

TABLE 392            FRANCE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         302

TABLE 393            SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            303

TABLE 394            SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            303

TABLE 395            SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            304

TABLE 396            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         304

TABLE 397            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION) 305

TABLE 398            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            305

TABLE 399            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         306

TABLE 400            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              306

TABLE 401            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            306

TABLE 402            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 307

TABLE 403            SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH,

AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            307

TABLE 404            DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              308

TABLE 405            DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            308

TABLE 406            DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            309

TABLE 407            DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 309

TABLE 408            DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            310

TABLE 409            DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       310

TABLE 410            DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         311

TABLE 411            DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              311

TABLE 412            DENMARK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         311

TABLE 413            DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            312

TABLE 414            DENMARK: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         312

TABLE 415            ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              313

TABLE 416            ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            313

TABLE 417            ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              314

TABLE 418            ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 314

TABLE 419            ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         315

TABLE 420            ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       315

TABLE 421            ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            316

TABLE 422            ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            316

TABLE 423            ITALY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            316

TABLE 424            ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         317

TABLE 425            ITALY: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         317

TABLE 426            SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              318

TABLE 427            SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            318

TABLE 428            SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            319

TABLE 429            SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 319

TABLE 430            SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         320

TABLE 431            SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       320

TABLE 432            SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            321

TABLE 433            SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            321

TABLE 434            SPAIN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            321

TABLE 435            SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         322

TABLE 436            SPAIN: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         322

TABLE 437            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            323

TABLE 438            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            324

TABLE 439            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            324

TABLE 440            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         325

TABLE 441            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            325

TABLE 442            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)                326

TABLE 443            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 326

TABLE 444            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              327

TABLE 445            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION) 327

TABLE 446            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       327

TABLE 447            REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        328

TABLE 448            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            330

TABLE 449            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)       330

TABLE 450            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            331

TABLE 451            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            331

TABLE 452            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         332

TABLE 453            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION) 332

TABLE 454            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            333

TABLE 455            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         333

TABLE 456            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              334

TABLE 457            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         334

TABLE 458            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 334

TABLE 459            ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        335

TABLE 460            ASIA PACIFIC: KEY MACRO INDICATORS                 336

TABLE 461            CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              337

TABLE 462            CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            338

TABLE 463            CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            338

TABLE 464            CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 339

TABLE 465            CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         339

TABLE 466            CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       340

TABLE 467            CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            340

TABLE 468            CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            341

TABLE 469            CHINA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            341

TABLE 470            CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         341

TABLE 471            CHINA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         342

TABLE 472            JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              343

TABLE 473            JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            343

TABLE 474            JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            344

TABLE 475            JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 344

TABLE 476            JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         345

TABLE 477            JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       345

TABLE 478            JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            346

TABLE 479            JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            346

TABLE 480            JAPAN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            346

TABLE 481            JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         347

TABLE 482            JAPAN: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         347

TABLE 483            INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              348

TABLE 484            INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            349

TABLE 485            INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            349

TABLE 486            INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 350

TABLE 487            INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         350

TABLE 488            INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       351

TABLE 489            INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            351

TABLE 490            INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            352

TABLE 491            INDIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            352

TABLE 492            INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         352

TABLE 493            INDIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         353

TABLE 494            AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              354

TABLE 495            AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            354

TABLE 496            AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            355

TABLE 497            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            355

TABLE 498            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION) 356

TABLE 499            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            356

TABLE 500            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         357

TABLE 501            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              357

TABLE 502            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         357

TABLE 503            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 358

TABLE 504            AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH,

AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            358

TABLE 505            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            359

TABLE 506            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            359

TABLE 507            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            360

TABLE 508            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         360

TABLE 509            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION) 361

TABLE 510            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            361

TABLE 511            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         362

TABLE 512            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              362

TABLE 513            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            362

TABLE 514            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 363

TABLE 515            SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        363

TABLE 516            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            364

TABLE 517            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            365

TABLE 518            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            365

TABLE 519            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 366

TABLE 520            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            366

TABLE 521            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)                367

TABLE 522            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 367

TABLE 523            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION) 368

TABLE 524            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION) 368

TABLE 525            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       368

TABLE 526            REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        369

TABLE 527            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            370

TABLE 528            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            370

TABLE 529            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            371

TABLE 530            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            371

TABLE 531            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         372

TABLE 532            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            372

TABLE 533            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)                373

TABLE 534            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         373

TABLE 535            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              374

TABLE 536            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION) 374

TABLE 537            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       374

TABLE 538            LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        375

TABLE 539            LATIN AMERICA: KEY MACRO INDICATORS                 376

TABLE 540            BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              377

TABLE 541            BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            377

TABLE 542            BRAZIL: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            378

TABLE 543            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 378

TABLE 544            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            379

TABLE 545            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       379

TABLE 546            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            380

TABLE 547            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            380

TABLE 548            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            380

TABLE 549            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         381

TABLE 550            BRAZIL: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         381

TABLE 551            MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              382

TABLE 552            MEXICO: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            382

TABLE 553            MEXICO: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            383

TABLE 554            MEXICO: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 383

TABLE 555            MEXICO: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            384

TABLE 556            MEXICO: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       384

TABLE 557            MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            385

TABLE 558            MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            385

TABLE 559            MEXICO: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            385

TABLE 560            MEXICO: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         386

TABLE 561            MEXICO: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         386

TABLE 562            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            387

TABLE 563            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            387

TABLE 564            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            388

TABLE 565            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 388

TABLE 566            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            389

TABLE 567            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)         389

TABLE 568            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 390

TABLE 569            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION) 390

TABLE 570            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION) 390

TABLE 571            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       391

TABLE 572            REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        391

TABLE 573            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY COUNTRY/REGION,

2022–2029 (USD MILLION)            392

TABLE 574            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            392

TABLE 575            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            393

TABLE 576            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            393

TABLE 577            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         394

TABLE 578            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION) 394

TABLE 579            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            395

TABLE 580            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         395

TABLE 581            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              396

TABLE 582            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         396

TABLE 583            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 396

TABLE 584            MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        397

TABLE 585            MIDDLE EAST: KEY MACROINDICATORS                 398

TABLE 586            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            398

TABLE 587            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            399

TABLE 588            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            399

TABLE 589            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            400

TABLE 590            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         400

TABLE 591            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            401

TABLE 592            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)         401

TABLE 593            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 402

TABLE 594            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              402

TABLE 595            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION) 402

TABLE 596            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       403

TABLE 597            GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH,

AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            403

TABLE 598            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            404

TABLE 599            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            405

TABLE 600            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            405

TABLE 601            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         406

TABLE 602            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION) 406

TABLE 603            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            407

TABLE 604            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         407

TABLE 605            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,

BY INDUSTRY, 2022–2029 (USD MILLION)              408

TABLE 606            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,

BY TYPE, 2022–2029 (USD MILLION)         408

TABLE 607            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 408

TABLE 608            SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        409

TABLE 609            UAE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)            409

TABLE 610            UAE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            410

TABLE 611            UAE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              410

TABLE 612            UAE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,

2022–2029 (USD MILLION)            411

TABLE 613            UAE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS,

BY TYPE, 2022–2029 (USD MILLION)         411

TABLE 614            UAE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)            412

TABLE 615            UAE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            412

TABLE 616            UAE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            413

TABLE 617            UAE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            413

TABLE 618            UAE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            413

TABLE 619            UAE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                414

TABLE 620            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            414

TABLE 621            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)            415

TABLE 622            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            415

TABLE 623            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            416

TABLE 624            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)         416

TABLE 625            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)     417

TABLE 626            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            417

TABLE 627            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            418

TABLE 628            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            418

TABLE 629            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                418

TABLE 630            REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            419

TABLE 631            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TOOL,

2022–2029 (USD MILLION)            420

TABLE 632            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            420

TABLE 633            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            421

TABLE 634            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 421

TABLE 635            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            422

TABLE 636            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)         422

TABLE 637            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 423

TABLE 638            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION) 423

TABLE 639            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION) 423

TABLE 640            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       424

TABLE 641            REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        424

TABLE 642            AFRICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)              425

TABLE 643            AFRICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)            425

TABLE 644            AFRICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            426

TABLE 645            AFRICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)                 426

TABLE 646            AFRICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)            427

TABLE 647            AFRICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)       427

TABLE 648            AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)            428

TABLE 649            AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)            428

TABLE 650            AFRICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)            428

TABLE 651            AFRICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,

BY TYPE, 2022–2029 (USD MILLION)         429

TABLE 652            AFRICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)         429

TABLE 653            MACROECONOMIC OUTLOOK FOR SYNTHETIC BIOLOGY MARKET IN AFRICA    430

TABLE 654            SYNTHETIC BIOLOGY MARKET: KEY DEVELOPMENTS OF

MAJOR PLAYERS, 2021–2024          432

TABLE 655            SYNTHETIC BIOLOGY MARKET: DEGREE OF COMPETITION 435

TABLE 656            SYNTHETIC BIOLOGY MARKET: REGION FOOTPRINT       439

TABLE 657            SYNTHETIC BIOLOGY MARKET: TOOL FOOTPRINT       439

TABLE 658            SYNTHETIC BIOLOGY MARKET: TECHNOLOGY FOOTPRINT       440

TABLE 659            SYNTHETIC BIOLOGY MARKET: APPLICATION FOOTPRINT       441

TABLE 660            SYNTHETIC BIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES              444

TABLE 661            SYNTHETIC BIOLOGY MARKET: COMPETITIVE BENCHMARKING

OF STARTUPS/SMES       445

TABLE 662            SYNTHETIC BIOLOGY MARKET: PRODUCT LAUNCHES,

JANUARY 2021–SEPTEMBER 2024                448

TABLE 663            SYNTHETIC BIOLOGY MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024                449

TABLE 664            SYNTHETIC BIOLOGY MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024                450

TABLE 665            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          452

TABLE 666            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED               453

TABLE 667            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,

JANUARY 2021–SEPTEMBER 2024                455

TABLE 668            THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–SEPTEMBER 2024                455

TABLE 669          THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–

SEPTEMBER 2024              456

TABLE 670            MERCK KGAA: COMPANY OVERVIEW     458

TABLE 671            MERCK KGAA: PRODUCTS/SERVICES OFFERED                 459

TABLE 672            MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024              461

TABLE 673            NOVOZYMES A/S: COMPANY OVERVIEW                 463

TABLE 674            NOVOZYMES A/S: PRODUCTS/SERVICES OFFERED             464

TABLE 675            NOVOZYMES A/S: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024                465

TABLE 676            NOVOZYMES A/S: DEALS, JANUARY 2021–SEPTEMBER 2024              466

TABLE 677            EUROFINS SCIENTIFIC: COMPANY OVERVIEW                 468

TABLE 678            EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED             469

TABLE 679            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          471

TABLE 680            AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED               472

TABLE 681            AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES,

JANUARY 2021–SEPTEMBER 2024                474

TABLE 682            AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024                474

TABLE 683            AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024                475

TABLE 684            AMYRIS, INC.: COMPANY OVERVIEW      476

TABLE 685            AMYRIS, INC.: PRODUCTS/SERVICES OFFERED                 476

TABLE 686            AMYRIS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024              477

TABLE 687            CODEXIS, INC.: COMPANY OVERVIEW   478

TABLE 688            CODEXIS, INC.: PRODUCTS/SERVICES OFFERED                 479

TABLE 689            CODEXIS, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024   481

TABLE 690            CODEXIS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024              481

TABLE 691            CODEXIS, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              482

TABLE 692            TWIST BIOSCIENCE: COMPANY OVERVIEW                 483

TABLE 693            TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED             484

TABLE 694            TWIST BIOSCIENCE: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024                485

TABLE 695            TWIST BIOSCIENCE: DEALS, JANUARY 2021–SEPTEMBER 2024              487

TABLE 696            TWIST BIOSCIENCE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024   488

TABLE 697            GENSCRIPT: COMPANY OVERVIEW         489

TABLE 698            GENSCRIPT: PRODUCTS/SERVICES OFFERED                 490

TABLE 699            GENSCRIPT: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024   492

TABLE 700            GENSCRIPT: DEALS, JANUARY 2021–SEPTEMBER 2024        493

TABLE 701            GENSCRIPT: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              493

TABLE 702            PRECIGEN: COMPANY OVERVIEW            494

TABLE 703            PRECIGEN: PRODUCTS/SERVICES OFFERED                 495

TABLE 704            GINKGO BIOWORKS: COMPANY OVERVIEW                 497

TABLE 705            GINKGO BIOWORKS: PRODUCTS/SERVICES OFFERED             498

TABLE 706            GINKGO BIOWORKS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024                499

TABLE 707            GINKGO BIOWORKS: DEALS, JANUARY 2021–SEPTEMBER 2024              499

TABLE 708            VIRIDOS: COMPANY OVERVIEW                503

TABLE 709            VIRIDOS: PRODUCTS/SERVICES OFFERED                 504

TABLE 710            VIRIDOS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024              505

TABLE 711            VIRIDOS: DEALS, JANUARY 2021–SEPTEMBER 2024        507

TABLE 712            VIRIDOS: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024   508

TABLE 713            SYNTHEGO: COMPANY OVERVIEW          509

TABLE 714            SYNTHEGO: PRODUCTS/SERVICES OFFERED                 509

TABLE 715            SYNTHEGO: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024   511

TABLE 716            SYNTHEGO: DEALS, JANUARY 2021–SEPTEMBER 2024        512

TABLE 717            SYNTHEGO: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024              512

TABLE 718            CREATIVE ENZYMES: COMPANY OVERVIEW                 513

TABLE 719            CREATIVE ENZYMES: PRODUCTS/SERVICES OFFERED             513

TABLE 720            CYRUS BIOTECHNOLOGY: COMPANY OVERVIEW          515

TABLE 721            CYRUS BIOTECHNOLOGY: PRODUCTS/SERVICES OFFERED               515

TABLE 722            CYRUS BIOTECHNOLOGY: DEALS, JANUARY 2021–SEPTEMBER 2024   516

LIST OF FIGURES

FIGURE 1              SYNTHETIC BIOLOGY MARKET SEGMENTATION              46

FIGURE 2              RESEARCH DESIGN         49

FIGURE 3              BREAKDOWN OF PRIMARIES: SYNTHETIC BIOLOGY MARKET          51

FIGURE 4              SYNTHETIC BIOLOGY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023      52

FIGURE 5              GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE

ANALYSIS-BASED ESTIMATION), 2023     53

FIGURE 6              ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.:

REVENUE SHARE ANALYSIS (2023)            53

FIGURE 7              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             54

FIGURE 8              MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH                55

FIGURE 9              SYNTHETIC BIOLOGY MARKET: CAGR PROJECTION     56

FIGURE 10            DATA TRIANGULATION METHODOLOGY                 58

FIGURE 11            SYNTHETIC BIOLOGY MARKET, BY TOOL, 2024 VS. 2029 (USD MILLION)                61

FIGURE 12            SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)      62

FIGURE 13            SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)       63

FIGURE 14            GEOGRAPHICAL SNAPSHOT OF SYNTHETIC BIOLOGY MARKET (2024-2029)   64

FIGURE 15            ADVANCEMENTS IN SYNTHETIC BIOLOGY AND RISING DEMAND FOR

BIO-BASED PRODUCTS TO DRIVE MARKET         65

FIGURE 16            MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST

MARKET SHARE IN 2023 66

FIGURE 17            MEDICAL APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD    67

FIGURE 18            CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD         67

FIGURE 19            SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     68

FIGURE 20            TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS   77

FIGURE 21            SYNTHETIC BIOLOGY MARKET: VALUE CHAIN ANALYSIS            78

FIGURE 22            SYNTHETIC BIOLOGY MARKET: ECOSYSTEM ANALYSIS            80

FIGURE 23            SYNTHETIC BIOLOGY MARKET: PATENT ANALYSIS, 2013–2023       88

FIGURE 24            SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS           98

FIGURE 25            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS         100

FIGURE 26            KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 101

FIGURE 27            NORTH AMERICA: MARKET SNAPSHOT 260

FIGURE 28            ASIA PACIFIC: MARKET SNAPSHOT          329

FIGURE 29            REVENUE ANALYSIS OF KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET,

2019–2023 (USD MILLION)            433

FIGURE 30            MARKET SHARE ANALYSIS OF KEY PLAYERS IN SYNTHETIC

BIOLOGY MARKET, 2023                434

FIGURE 31            SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023       437

FIGURE 32            SYNTHETIC BIOLOGY MARKET: COMPANY FOOTPRINT       438

FIGURE 33            SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2023                443

FIGURE 34            EV/EBITDA OF KEY VENDORS, 2023         446

FIGURE 35            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK

BETA OF KEY VENDORS                446

FIGURE 36            SYNTHETIC BIOLOGY MARKET: BRAND/PRODUCT COMPARISON             447

FIGURE 37            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)             453

FIGURE 38            MERCK KGAA: COMPANY SNAPSHOT (2023)                 459

FIGURE 39            NOVOZYMES A/S: COMPANY SNAPSHOT (2023)                 464

FIGURE 40            EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)    469

FIGURE 41            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)             472

FIGURE 42            CODEXIS, INC.: COMPANY SNAPSHOT (2023)                 479

FIGURE 43            TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)    484

FIGURE 44            GENSCRIPT: COMPANY SNAPSHOT (2023)                 490

FIGURE 45            PRECIGEN: COMPANY SNAPSHOT (2023)                 494

FIGURE 46            GINKGO BIOWORKS: COMPANY SNAPSHOT (2023)    497